{"id":142404,"date":"2019-07-12T05:43:25","date_gmt":"2019-07-12T05:43:25","guid":{"rendered":"https:\/\/labinsights.com\/acf_article\/penggunaan-nt-probnp-di-lingkungan-rumah-sakit-dan-rawat-jalan-menerjemahkan-bukti-ilmiah-ke-praktik-klinis\/"},"modified":"2026-01-06T11:59:31","modified_gmt":"2026-01-06T11:59:31","slug":"the-use-of-nt-probnp-in-hospital-and-ambulatory-settings-translating-the-evidence-to-clinical-practice","status":"publish","type":"acf_article","link":"https:\/\/labinsights.com\/id\/disease-area\/cardiology\/the-use-of-nt-probnp-in-hospital-and-ambulatory-settings-translating-the-evidence-to-clinical-practice\/","title":{"rendered":"Penggunaan NT-proBNP di lingkungan rumah sakit dan rawat jalan: Menerjemahkan bukti ilmiah ke praktik klinis."},"content":{"rendered":"<p>NT-proBNP telah terbukti menjadi biomarker yang berguna untuk evaluasi prognosis pada pasien gagal jantung kronis, namun masih belum jelas bagaimana bukti prognostik tersebut dapat diterjemahkan ke dalam praktik klinis untuk meningkatkan tata laksana gagal jantung. Asia Pacific Cardiac Webinar mempertemukan para pakar global dan regional untuk membahas penggunaan praktis NT-proBNP sebagai penanda prognosis dalam tata laksana gagal jantung kronis di berbagai lingkungan klinis. Anggota-anggotanya termasuk James L. Januzzi, MD dari Amerika Serikat;\u00a0Yi-Heng Li, MD, PhD, FACC, FESC dari Taiwan; dan\u00a0Prof. Dr. Naoki Sato, MD, PhD, FESC, FJCA, FJCC dari Jepang. Lihat video di bawah ini untuk memahami:<\/p>\n<ul>\n<li>Rekomendasi Konsensus Pakar APAC mengenai ambang nilai prognostik NT-proBNP untuk menentukan pasien yang berisiko lebih tinggi mengalami luaran buruk di berbagai lingkungan klinis.<\/li>\n<li>Bagaimana cara memasukkan informasi prognostik NT-proBNP ke dalam pengambilan keputusan klinis untuk meningkatkan tata laksana pasien gagal jantung.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>NT-proBNP telah terbukti menjadi biomarker yang berguna untuk evaluasi prognosis pada pasien gagal jantung kronis, namun masih belum jelas bagaimana bukti prognostik tersebut dapat diterjemahkan ke dalam praktik klinis untuk meningkatkan tata laksana gagal jantung. Asia Pacific Cardiac Webinar mempertemukan para pakar global dan regional untuk membahas penggunaan praktis NT-proBNP sebagai penanda prognosis dalam tata [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":89884,"parent":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"tags":[12896,12895,12858],"pillarandcategory":[283,282,296,317,309,299],"reporter":[13289,13290,13288],"class_list":["post-142404","acf_article","type-acf_article","status-publish","has-post-thumbnail","hentry","tag-imunoasai","tag-kardiologi","tag-12858","pillarandcategory-cardiology","pillarandcategory-disease-area","pillarandcategory-event-coverage","pillarandcategory-immunoassay","pillarandcategory-operations","pillarandcategory-webinars","reporter-james-l-januzzi","reporter-naoki-sato","reporter-yi-heng-li"],"acf":[],"_links":{"self":[{"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/acf_article\/142404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/acf_article"}],"about":[{"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/types\/acf_article"}],"author":[{"embeddable":true,"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/acf_article\/142404\/revisions"}],"predecessor-version":[{"id":142594,"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/acf_article\/142404\/revisions\/142594"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/media\/89884"}],"wp:attachment":[{"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/media?parent=142404"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/tags?post=142404"},{"taxonomy":"pillarandcategory","embeddable":true,"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/pillarandcategory?post=142404"},{"taxonomy":"reporter","embeddable":true,"href":"https:\/\/labinsights.com\/id\/wp-json\/wp\/v2\/reporter?post=142404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}